Clincosm LogoSign in Get a demo

Enabling Independent Living by Expanding Access to Home-Based Pulmonary Rehabilitation

Sponsor
Mayo Clinic (Other)
Overall Status
Completed
CT.gov ID
NCT04479969
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (NIH)
9
Enrollment
1
Location
1
Arm
4.3
Actual Duration (Months)
2.1
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The purpose of this study is to test an existing home-based pulmonary rehab program with the addition of video chat and a capability of a Spanish version.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Video Chat
 N/A

Detailed Description

The purpose of this research is to test video chat on a computer tablet that is used for Pulmonary Rehabilitation. We are interested in learning patients' thoughts on how easy or difficult video chat is to use and the translation to Spanish and the feed back from Spanish speaking patients .

Study Design

Study Type:
Interventional
Actual Enrollment :
9 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Enabling Independent Living by Expanding Access to Home-Based Pulmonary Rehabilitation
Actual Study Start Date :
Mar 22, 2021
Actual Primary Completion Date :
Jul 30, 2021
Actual Study Completion Date :
Jul 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Other: Intervention

This is a small study to assess the usability of video conferencing. A total of 10 patients will be enrolled, 5 of which will be Spanish speakers. All patients will test the video conferencing.

Behavioral: Video Chat
Video chat with health coach using a computer tablet.

Outcome Measures

Primary Outcome Measures

  1. Qualitative Interview [Week 1]

    A Qualitative Interview will be conducted over the phone asking about the video chat experience.

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

  • Patients must be ≥ 40 years old.

  • Patients mist have a diagnosis of GOLD stage II, III, or IV COPD documented by pulmonary function testing.

  • Patients must be a current or previous smoker with at least 10 pack-years of cigarette smoking.

Additional Inclusion Criteria to test Spanish version of system:
  • Be a native Spanish speaker.
Exclusion Criteria:

  • Patients with a high likelihood of being lost to follow-up or contact (patients with active chemical dependency).

  • Patients planning to move out of the state or who are not living in the healthcare area.

  • Patients with an inability to provide good data or follow commands (patients who are disoriented, have a severe neurologic or psychiatric condition).

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mayo Clinic in Rochester Rochester Minnesota United States 55905

Sponsors and Collaborators

  • Mayo Clinic
  • National Heart, Lung, and Blood Institute (NHLBI)

Investigators

  • Principal Investigator: Roberto P Benzo, Mayo Clinic

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Roberto P. Benzo, Principal Investigator, Mayo Clinic
ClinicalTrials.gov Identifier:
NCT04479969
Other Study ID Numbers:
  • 20-003806
  • 1R43HL151461
First Posted:
Jul 21, 2020
Last Update Posted:
Jul 8, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive

Study Results

No Results Posted as of Jul 8, 2022